Cogent Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
16 Feb 24 | BuyUS$8,749,995 | Fairmount Funds Management LLC | Company | 1,166,666 | US$7.50 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,996 | 0.00171% |
VC/PE Firms | 12,648,542 | 10.8% |
Hedge Funds | 23,005,302 | 19.7% |
Institutions | 81,067,126 | 69.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
13,208,972 | US$118.6m | 58.8% | 0.01% | |||
9,239,731 | US$83.0m | -0.22% | 6.55% | |||
7,991,587 | US$71.8m | 9.65% | no data | |||
7,539,930 | US$67.7m | -22.6% | 4.62% | |||
6,964,375 | US$62.5m | 0% | 5.34% | |||
6,225,641 | US$55.9m | 0% | 4.47% | |||
5,714,405 | US$51.3m | 8.64% | no data | |||
5,684,167 | US$51.0m | 0% | 2.37% | |||
4,609,762 | US$41.4m | 27.2% | 1.47% | |||
4,484,380 | US$40.3m | -6.57% | 2.23% | |||
4,066,034 | US$36.5m | -4.3% | 0.06% | |||
3,744,263 | US$33.6m | 0% | 0.57% | |||
3,231,462 | US$29.0m | -15.8% | no data | |||
2,280,793 | US$20.5m | 15.2% | no data | |||
2,265,230 | US$20.3m | -18.3% | 1.7% | |||
2,000,000 | US$18.0m | 0% | 2.14% | |||
1,712,899 | US$15.4m | 2.33% | 6.45% | |||
1,613,616 | US$14.5m | 31% | 0.01% | |||
1,305,000 | US$11.7m | 0% | 1.93% | |||
1,221,362 | US$11.0m | 1.26% | 2.59% | |||
1,122,471 | US$10.1m | -50% | 0.86% | |||
1,001,000 | US$9.0m | 0.03% | 0.51% | |||
1,000,051 | US$9.0m | 0.01% | no data | |||
936,576 | US$8.4m | 0% | 0.34% | |||
919,635 | US$8.3m | -34.3% | 0.14% |